» Articles » PMID: 7665620

Molecular Cloning and Expression of Megakaryocyte Potentiating Factor CDNA

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1995 Sep 15
PMID 7665620
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

The human megakaryocyte potentiating factor (hMPF) has been previously purified from a culture supernatant of human pancreatic cancer cells HPC-Y5 (Yamaguchi, N., Hattori, K., Oh-eda, M., Kojima, T., Imai, N., and Ochi, N. (1994) J. Biol. Chem. 269, 805-808). We have now isolated hMPF cDNA from a HPC-Y5 cDNA library using polymerase chain reaction and plaque hybridization methods. The hMPF cDNA encodes a polypeptide consisting of 622 amino acids, including a signal peptide of 33 amino acids, and with a deduced molecular mass of 68 kDa, although HPC-Y5 cells secrete a 33-kDa form of hMPF. Human MPF does not show any significant homology with other previously described sequences. The cDNA was expressed in COS-7 and Chinese hamster ovary (CHO) cells, and megakaryocyte potentiating activity was detected in their culture supernatant. The COS-7 cells secreted only a 33-kDa recombinant hMPF, whereas an additional 30-kDa form was detected in the culture medium of CHO cells. The 33-kDa rhMPF purified from CHO cells showed megakaryocyte potentiating activity, but not the purified 30-kDa rhMPF. The difference in structure and activity between the 33- and 30-kDa forms of hMPF was ascribed to the existence in the 33-kDa form of the C-terminal 25 amino acid residues.

Citing Articles

Characterization of mesothelin gene expression in dogs and overexpression in canine mesotheliomas.

Nabeta R, Kanaya A, Shimada K, Matsuura K, Yoshimura A, Oyamada T Front Vet Sci. 2024; 11:1436621.

PMID: 39315086 PMC: 11417096. DOI: 10.3389/fvets.2024.1436621.


Serum Levels of N- and C-ERC/Mesothelin and Clinicopathological Factors in Mesothelioma Patients and Those without Mesothelioma.

Koyanagi A, Kajino K, Nojiri S, Abe M, Kobayashi T, Sugitani Y Juntendo Iji Zasshi. 2024; 69(2):124-136.

PMID: 38854453 PMC: 11153076. DOI: 10.14789/jmj.JMJ22-0042-OA.


A bispecific antibody that targets the membrane-proximal region of mesothelin and retains high anticancer activity in the presence of shed mesothelin.

Chakraborty A, Onda M, OShea T, Wei J, Liu X, Bera T Mol Cancer Ther. 2024; .

PMID: 38647528 PMC: 11493849. DOI: 10.1158/1535-7163.MCT-23-0233.


Circulating and non-circulating proteins and nucleic acids as biomarkers and therapeutic molecules in ovarian cancer.

Utkarsh K, Kumar A, Aditi , Khan A, Nayyar A, Haque S Genes Dis. 2023; 10(3):1005-1018.

PMID: 37396515 PMC: 10308119. DOI: 10.1016/j.gendis.2022.07.004.


Structures of Cancer Antigen Mesothelin and Its Complexes with Therapeutic Antibodies.

Zhan J, Lin D, Watson N, Esser L, Tang W, Zhang A Cancer Res Commun. 2023; 3(2):175-191.

PMID: 36968141 PMC: 10035497. DOI: 10.1158/2767-9764.CRC-22-0306.